DEA Toxicology Testing

Closed Solicitation Posted

Solicitation number
RFP-15DDHQ24R0000016
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
621511 Medical Laboratories
Place of performance
Springfield, Virginia 22152, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Drug Enforcement Administration (DEA) is seeking a contractor to provide toxicology testing services for the agency's Diversion Control Division. The contractor will be required to analyze biological samples obtained from drug overdoses to identify novel psychoactive substances and commonly abused drugs. The contract will be a firm-fixed-price Blanket Purchase Agreement with a 12-month base period and four 1-year option periods. The contractor must have an active DEA registration, be SAM certified, and provide a risk mitigation plan. Proposals are due by April 22, 2024, and the award is anticipated by June 1, 2024. Pricing will be evaluated based on fixed unit prices for sample analysis, consumable supplies, and standards.

The solicitation is not set-aside for any particular business category. The North American Industry Classification System (NAICS) code is 541380 - Testing Laboratories, and the Product Service Code (PSC) is R425 - Support - Professional: Laboratory. The incumbent contractor is unknown. The DEA estimates a requirement of up to 1,000 samples annually, with a potential five-year contract value. The place of performance is West Springfield, VA 22152, USA.

Notice text

3 versions

Update #3 · Latest ·

1.  Amendment No: 0002 is issued to RFP 15DDHQR00000016 to provide the Government's response to questions. (See attached amendment 0002).

Diversion Control’s Drug & Chemical Evaluation Section requires a new contract to replace the current BPA for DEA’s Toxicology Testing Program (DEA TOX). DEA would require a contractor to analyze the biological samples provided from such overdoses related to abuse of various drugs being encountered.

Update #2 ·

**Amendment No. 0001 is issued to RFP 15DDHQR00000016 (SEE ATTACHED).**

Diversion Control’s Drug & Chemical Evaluation Section requires a new contract to replace the current BPA for DEA’s Toxicology Testing Program (DEA TOX). DEA would require a contractor to analyze the biological samples provided from such overdoses related to abuse of various drugs being encountered.

Update #1 ·

Diversion Control’s Drug & Chemical Evaluation Section requires a new contract to replace the current BPA for DEA’s Toxicology Testing Program (DEA TOX). DEA would require a contractor to analyze the biological samples provided from such overdoses related to abuse of various drugs being encountered.

Files

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity